Abstract
Polymyositis may occur along with other manifestations of chronic graft vs host disease after allogeneic bone marrow transplantation (BMT). Donor lymphocyte infusion (DLI) could produce durable remissions in relapsed patients with chronic myelogenous leukemia (CML) but it may contribute to the development of polymyositis. We report in this study a 25-year-old man who suffered from a relapse of CML 4 years after a sibling human leukocyte antigen-matched allogenic BMT. The patient developed polymyositis 18 months after DLI. Mini-pulse therapy with methylprednisolone was effective for his proximal weakness and elevated creatine phosphokinase. There was no relapse of symptoms of polymyositis on tapering of the medication.
References
Biju G, Debashis D, Mammen C, Alok S, Vikram M et al (2001) Polymyositis—an unusual manifestation of chronic graft-versus-host disease. Rheumatol Int 20:169–170
Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsten N, Arcese W et al (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86:2041–2050
Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B (1999) Myasthenia gravis and polymyositis as manifestations of chronic GVHD. Bone Marrow Transplant 23:397–399
Reyes M, Noronha P, Thomas W, Heredia R (1983) Myositis of chronic GVHD. Neurology 33:1222–1224
Adams C, August CS, Maguire H, Sladky JT (1995) Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 12:58–61
Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555
Moller E, Bohme J, Valugerdi MA, Ridderstad A, Olerup O (1990) Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of autoreactive T lymphocytes. Immunol Rev 118:5–19
Couriel DR, Beguelin GZ, Giralt S, Lima MD, Hosing C, Kharfan-Dabaja MA (2002) Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 30:543–546
Megan S, Frederic P, Steven M, Susan L, Dina W, David W et al (1999) Mixed lymphohaemopoetic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation. Lancet 353:1755–1759
Pier N, Dubowitz V (1983) Chronic graft versus host disease presenting with polymyositis. Br Med J 286:2024
Leber B, Warlker IR, Rodriguez A, McBride JA, Carter R, Brain MC et al (1993) Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Bone Marrow Transplant 12:405–407
Y Oshima, S Takahashi, H Nagayama, K Nishiwaki, Y Kobayashi, A Tojo et al (1997) Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT). Bone Marrow Transplant 19:737–740
Silberstein L, Davies A, Kelsey S, Foran J, Murrell C, D’Cruz D et al (2001) Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant 27:231–233
Lin P-C, Hsiao L-T, Chen P-M (2005) Acute polymyositis after donor lymphocyte infusion. Eur J Haematol 74:166–168
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, FC., Chen, CH. & Chao, TY. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature. Clin Rheumatol 26, 1207–1210 (2007). https://doi.org/10.1007/s10067-006-0346-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0346-7